On Aug. 3, TrialSite applauded the effort of Lilly & Co. (NYSE: LLY) and the National Institute of Allergy and Infectious Diseases (NIAID) for the Blaze-2 clinical trial. Why? Because it’s one of the first, if not the first nationwide intervention during the...
BLAZE-2
Category
Care Access Research Partners on Revolutionary Mobile Clinical Trial for COVID-19 Treatment
Care Access Research is a research site partner on Eli Lilly and Company’s trial, providing mobile research site capabilities to quickly scale and complete vital COVID-19 trial Care Access Research, the leader in rapid development and management of high-performing...